PCM
PRAH

Prelude Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Prelude Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-117,719
Closed -$19.4M – 2211
2021
Q2 		$19.4M Buy
117,719
+116,221
+7,758% +$19.4M 0.58% 17
2021
Q1 		$230K Buy
+1,498
New +$203K 0.01% 1265
2020
Q3 		– Sell
-388
Closed -$38K – 2568
2020
Q2 		$38K Sell
388
-675
-63% -$62.8K ﹤0.01% 1231
2020
Q1 		$88K Buy
+1,063
New +$104K 0.01% 631
2019
Q4 		– Sell
-1,125
Closed -$112K – 2379
2019
Q3 		$112K Buy
1,125
+445
+65% +$44.2K 0.01% 913
2019
Q2 		$67K Buy
680
+200
+42% +$19.1K ﹤0.01% 1050
2019
Q1 		$53K Buy
+480
New +$50.2K ﹤0.01% 1110
2016
Q3 		– Sell
-1,000
Closed -$42K – 1909
2016
Q2 		$42K Sell
1,000
-1,216
-55% -$56K 0.01% 1073
2016
Q1 		$95K Buy
+2,216
New +$93.6K 0.01% 782

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Prelude Capital Management's PRAH Position: Q3 2021 in Review

Prelude Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 117,719 shares — an estimated $19.4M sold.

Prelude Capital Management first reported a position in PRAH in Q1 2016 and held it in 9 quarters. The position peaked at $19.4M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Prelude Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Prelude Capital Management sold 117,719 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19.4M.
  • Prelude Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 9 quarters.
  • Prelude Capital Management's PRA Health Sciences, Inc. position peaked at $19.4M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.